visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Jounce Therapeutics

    Get Full Access

    Description

    • Jounce Therapeutics, Inc. is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide longlasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounces lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in a Phase 1/2 trial. For more information, please visit http://jouncetx.com/We have many career opportunities at Jounce and are looking for exceptional individuals who share our passion and perseverance for developing highly durable cancer immunotherapies that can dramatically impact and improve patients lives.
    • location

      Headquarters:780 Memorial Drive , Cambridge, Massachusetts, United States

      More
    • Jounce Therapeutics phone

      Phone Number: +1 857-259-3840

    • Jounce Therapeutics website

      Website: https://www.jouncetx.com

    • Jounce Therapeutics employees

      Employees:155

    • Jounce Therapeutics revenue

      Revenue:$100 - 250M

    • Jounce Therapeutics legal name

      Legal Name:Jounce Therapeutics

    • Jounce Therapeutics's Social Media

      Jounce Therapeutics linkedin Jounce Therapeutics facebook Jounce Therapeutics twitter
    • done Is this data correct?

    • |  NAICS Code: 812199  |

      Show More
    Person level website identification

    CEO for Jounce Therapeutics

    Rich Murray

    Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Kim Drapkin

    Chief Financial Officer

    Dmitri Wiederschain

    Chief Scientific Officer

    Stephen Farrand

    Chief Technical Officer

    Hugh Cole

    Chief Business Officer And Head Of Corporate Development

    Beth Trehu

    Chief Medical Officer

    Frequently Asked Questions regarding Jounce Therapeutics

    • Where are Jounce Therapeutics's Headquarters?

      Jounce Therapeutics's Headquarters are in 780 Memorial Drive ,Cambridge,Massachusetts,United States

    • What is Jounce Therapeutics's phone number?

      Jounce Therapeutics's phone number is +1 857-259-3840

    • What is Jounce Therapeutics's official website?

      Jounce Therapeutics's official website is https://www.jouncetx.com

    • What is Jounce Therapeutics's Revenue?

      Jounce Therapeutics's revenue is $100 - 250M

    • What is Jounce Therapeutics's NAICS code?

      Jounce Therapeutics's NAICS code is 812199

    • How many employees are working in Jounce Therapeutics

      Jounce Therapeutics has 155 employees

    • What is Jounce Therapeutics's Industry?

      Jounce Therapeutics is in the industry of Biotechnology

    • Who is Jounce Therapeutics's CEO?

      Jounce Therapeutics's CEO is Rich Murray

    Company Directory